Keystone Financial Group (Kentucky)’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$660K Sell
39,404
-12
-0% -$201 0.06% 199
2025
Q1
$606K Sell
39,416
-738
-2% -$11.3K 0.06% 193
2024
Q4
$885K Sell
40,154
-1,450
-3% -$32K 0.09% 153
2024
Q3
$750K Sell
41,604
-1,400
-3% -$25.2K 0.1% 146
2024
Q2
$699K Sell
43,004
-2,400
-5% -$39K 0.25% 62
2024
Q1
$641K Sell
45,404
-950
-2% -$13.4K 0.09% 146
2023
Q4
$484K Sell
46,354
-900
-2% -$9.4K 0.08% 153
2023
Q3
$482K Sell
47,254
-1,300
-3% -$13.3K 0.08% 160
2023
Q2
$366K Buy
+48,554
New +$366K 0.06% 193
2022
Q4
$446K Sell
48,954
-300
-0.6% -$2.74K 0.09% 159
2022
Q3
$397K Buy
49,254
+2,908
+6% +$23.4K 0.08% 167
2022
Q2
$349K Sell
46,346
-2,500
-5% -$18.8K 0.07% 187
2022
Q1
$459K Buy
48,846
+1,250
+3% +$11.7K 0.08% 167
2021
Q4
$381K Sell
47,596
-200
-0.4% -$1.6K 0.06% 200
2021
Q3
$466K Buy
47,796
+3,200
+7% +$31.2K 0.08% 168
2021
Q2
$442K Buy
44,596
+4,400
+11% +$43.6K 0.08% 170
2021
Q1
$464K Hold
40,196
0.09% 162
2020
Q4
$388K Sell
40,196
-2,700
-6% -$26.1K 0.08% 162
2020
Q3
$386K Buy
42,896
+1,415
+3% +$12.7K 0.09% 153
2020
Q2
$511K Buy
41,481
+435
+1% +$5.36K 0.14% 127
2020
Q1
$369K Buy
41,046
+2,700
+7% +$24.3K 0.12% 133
2019
Q4
$376K Sell
38,346
-900
-2% -$8.83K 0.1% 152
2019
Q3
$270K Buy
39,246
+8,650
+28% +$59.5K 0.08% 185
2019
Q2
$282K Buy
30,596
+3,525
+13% +$32.5K 0.09% 172
2019
Q1
$424K Sell
27,071
-185
-0.7% -$2.9K 0.15% 128
2018
Q4
$420K Sell
27,256
-515
-2% -$7.94K 0.19% 111
2018
Q3
$596K Hold
27,771
0.24% 106
2018
Q2
$680K Buy
27,771
+4
+0% +$98 0.38% 69
2018
Q1
$466K Buy
27,767
+1,250
+5% +$21K 0.26% 90
2017
Q4
$507K Buy
+26,517
New +$507K 0.32% 65